T he US Food and Drug Administration (FDA) should approve clinical trials of a gene-therapy technique to create embryos with genetic material from three people -if certain conditions are met, the US National Academies of Sciences, Engineering and Medicine said on 3 February.
The controversial technique involves replacing the faulty energy-producing mitochondria in a woman's egg with mitochondria from the egg of a healthy donor. The aim is to prevent the transmission of disabling or fatal diseases caused by mutations in a mother's mitochondrial DNA. But concerns about the technique's safety, and the psychological and social implications of children with three genetic parents, have given US regulators pause. Moreover, a federal law approved late last year prevents the FDA from allowing any such trials in humans.
The academy panel suggests limiting the tests of mitochondrial replacement to male embryos as a safety precaution. Male offspring would not be able to pass their modified mitochondria to future generations, because a child inherits its mitochondria from its mother.
The report also outlines several extra steps to monitor the safety of mitochondrial replacement, such as attempting to track the children born as a result of the technique and sharing the resulting data with scientists and the public. If mitochondrial replacement is proved safe in male offspring, it could be expanded to female embryos, the advisory panel said.
By contrast, the United Kingdom last year approved mitochondrial replacement with no restrictions on the sex of a modified embryo.
Shoukhrat Mitalipov, a reproductivebiology specialist at the Oregon Health and Science University in Portland, sees the US advisory panel report as a hollow victory. In 2014, he applied to the FDA to perform a clinical trial of mitochondrial replacement therapy with human embryos -a trial that cannot take place under current US law.
Others disagree with the panel's conclusions. The new report "leapt to the conclusion that things should go forward despite all the concerns", says Marcy Darnovsky, executive director of the non-profit Center for Genetics and Society in Berkeley, California. ■
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US panel backs 'three-person' embryos
But regulators cannot approve clinical trials.
BY E R I K A C H E C K H AY D E N
P ublic-health authorities are investigating whether the Zika virus has caused an apparent surge in the number of infants born with microcephaly, or abnormally small heads, in at least seven countries. But conclusively determining whether the mosquito-borne virus is to blame could take months to years, researchers say.
Concerns first arose in Brazil, which in November declared a national public-health emergency. As of 2 February, officials there had investigated 1,113 of 4,783 suspected cases of microcephaly reported since late last year, and confirmed that 404 of those could be linked to Zika. On 1 February, a committee convened by the World Health Organization said that a causal link between Zika and microcephaly is "strongly suspected, though not yet scientifically proven".
That is not for a lack of effort. Work now under way includes case-control studies to compare rates of Zika infection in babies who are born with microcephaly and in those without it, as well as genetic sequencing of the virus and efforts to develop a molecular diagnostic test for Zika infection.
Making progress has been difficult because scientists know relatively little about Zika; there is no easy-to-use test to diagnose infections; and physicians disagree about how to define microcephaly, says Bruno Andrade, an immunologist at the Fiocruz research institute in Bahia, Brazil. "All of this started less than two months ago -that's when everything stepped up, " he says. "We are in the middle of this nightmare here. "
So far, two lines of evidence support a link between the virus and microcephaly. Microcephaly cases in Brazil started to rise around 6 months after authorities confirmed Zika transmission there, hinting that the defect might have been caused by in utero exposure to the virus. And researchers in Brazil have found traces of the virus, or antibodies to it, in the amniotic fluid, brains or spinal fluid of 15 fetuses and babies diagnosed with microcephaly. This is suggestive, but not conclusive. "Most of us believe it's highly plausible that Zika is the cause of this epidemic of microcephaly,
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Mosquito-borne virus is now present in 33 countries.
Pregnant women infected with the Zika virus are being monitored for effects on their unborn babies.
SCHNEYDER MENDOZA/AFP/GETTY but we need additional evidence, " says Albert Ko, an infectious-disease physician and epidemiologist at the Yale School of Public Health in New Haven, Connecticut.
In the hope of producing more-definitive data, the Brazilian ministry of health is now setting up large studies. In one, researchers will follow up 6,000 pregnant women in northeastern Brazil to investigate the effects of Zika and of microcephaly.
KNOWLEDGE GAPS
Epidemiological studies are often complex because Zika causes a relatively mild illness in adults and there is no widely deployed test for the virus. This means that most of the mothers who have participated in previous studies were never diagnosed with Zika, even if they had it. To address this problem, the Brazilian health ministry is now asking mothers whether they had Zika symptoms instead of whether they were diagnosed with Zika.
But many researchers say that epidemiological data alone will not convince them of a link between Zika and microcephaly; they would like to see evidence of how and why the virus causes the condition. With this in mind, scientists are developing animal models to investigate Zika's effects on the body, such as which tissues it infects, and why fetal brains might be especially vulnerable. "There's a lot of basic work and research that we need to do, " says Anthony Fauci, director of the US National Institute of Allergy and Infectious Diseases in Bethesda, Maryland.
It's plausible, for instance, that Zika crosses from mother to baby through the placenta, as do some related viruses, such as West Nile virus. But these other viruses don't often cause infant brain damage, so it's not clear why -or how -Zika might, says David Morens, a senior adviser to Fauci. The virus may be toxic only while a fetus's brain is still developing its major structures, in the first two months of pregnancy. Or it may persist in the body for a long period, which would explain why Zika is seen in stillborn babies with microcephaly. "If the insult happened early on, then why is the virus present at seven months when the miscarriage occurs?" Morens says. "There must be a combination of things going on. "
Another conundrum is what it is that makes these women and babies so vulnerable: the vast majority of women infected with Zika go on to have healthy babies.
But whatever scientists ultimately discover about Zika, another major challenge remains: supporting the children born with microcephaly. Many are living in what Ko calls a "vegetative state", and may go on to have seizures. That could be difficult for their families -many of which are impoverished -to bear.
"We have to start settling down and think about how we're going to take care of these kids, " Ko says. If there is a link between Zika and microcephaly, the number of babies affected by the condition could soar as the virus spreads, he cautions. "We have no idea how big it's going to get. " ■
CORRECTIONS
The two elements in the key for the map in the News story 'Microcephaly surge in doubt' (Nature 530, 13-14; 2016) were accidentally swapped round. The corrected graphic can be seen at go.nature. com/ekmksk. The dollar conversion of €4.6 billion in the News story 'Science hubs win in major revamp' (Nature 530, 18-19; 2016) should have been US$5 billion not $5 million. The News story 'Academics across Europe join 'Brexit' debate' (Nature 530, 15; 2016) erroneously stated that the latest UK contribution to the EU budget was €140 billion. In fact, it contributed around €17 billion.
"There's a lot of basic work and research that we need to do."
